1. Antonov IM. Efficacy and safety of indirect anticoagulant warfarin when dosing, based on the results of pharmacogenetic testing. PhD Thesis. Candidate. Moscow 2009; 22 r. Russian (Antonov I. M. Effektivnost' i bezopasnost' primeneniya neprya- mogo antikoagulyanta varfarina pri ego dozirovanii, osnovan- nom na rezul'tatakh farmakogeneticheskogo testirovaniya. Avtoref diss kand med nauk. Moskva 2009; 22 s).
2. Kozlova TV. Monitoring of treatment with oral anticoagulants. Pharmatec 2003; 3: 87–92. Russian (Kozlova T. V. Kontrol' za lecheniem oral'ny- mi antikoagulyantami. Farmateka 2003; 3: 87–92).
3. Kropacheva ES, Panchenko EP. Anticoagulants of indirect action in a therapeutic clinic overview. Russian Medical Journal: an independent publication for doctors in 2009; 17 (8): 507–13. Russian (Kropacheva E. S., Panchenko E. P.. Antikoagulyanty nepryamogo deistviya v terapevtiche- skoi klinike: Obzor. Russkii meditsinskii zhurnal: nezavisimoe izdanie dlya praktikuyushchikh vrachei 2009; 17 (8): 507–13).
4. Sychev DA, Kropacheva ES, Ignat’ev IV, et al. Pharmacogenetics indirect anticoagulants: the importance of genotype in enhancing the effectiveness and safety of treatment. Cardiology 2006; 7: 72–8. Russian (Sychev D. A., Kropacheva E. S., Ignat'ev I. V. i dr. Farmakogenetika nepryamykh antikoagulyantov: znachenie genotipa v povyshenii effektivnosti i bezopasnosti terapii. Kardiologiya 2006; 7: 72–8).
5. Sychev DA, Antonov IM, Zagrebin SV, et al. Warfarin dosing algorithms, based on the results of pharmacogenetic testing: a real opportunity to optimize pharmacotherapy. Rational Pharmacotherapy in Cardiology 2007; 2: 59–66. Russian (Sychev D. A., Antonov I. M., Zagrebin S. V. i dr. Algoritmy dozirovaniya varfarina, osnovannye na rezul'tatakh far- makogeneticheskogo testirovaniya: real'naya vozmozhnost' optimiza- tsii farmakoterapii. Ratsional'naya Farmakoterapiya v Kardiologii 2007; 2: 59–66).